bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.02.28.530486

Bacterial and molecular contamination of a small freshwater effluent used for drinking water

Abstract

Sewage contamination of freshwater occurs in the form of raw waste or as effluent (at varying levels of treatment) from wastewater treatment plants. Global management of this contamination has focused on detection of live sewage-indicating bacteria in freshwater, drinking water, and irrigation systems. While raw waste (animal and human) and underfunctioning WWTPs can introduce live enteric bacteria to freshwater systems, most WWTPs, even when operating correctly, do not remove bacterial genetic material from treated waste, resulting in the addition of concentrated enteric bacterial DNA (molecular contamination), including antibiotic resistance genes, into water columns and sediment of freshwater systems. In freshwater systems with both raw and treated waste inputs, then, there will be increased interaction between live sewage-associated bacteria (untreated sewage) and molecular contamination (from both untreated and treated wastewater effluent), with the potential of increasing antibiotic resistance in the live bacterial populations. To evaluate this understudied interaction between molecular and bacterial contamination in the freshwater environment, we conducted a three-month field-based study of sewage-associated bacteria and genetic material in water and sediment in a freshwater tributary of the Hudson River (NY, USA) that supplies drinking water and receives treated and untreated wastewater discharges from several municipalities. Using both molecular and culture-based bacterial analyses, we demonstrate both treated and untreated sewage influences on water and sediment bacterial communities in this tributary, and water-sediment exchanges of enteric bacteria and associated genetic material with rain events. Furthermore, treated sewage effluent on this waterway serves as a concentrated source of int1 (antibiotic resistance) genes, which appear to collect in the sediments below the outfall along with fecal indicating bacteria, serving as a possible genetic exchange substrate and a source for future molecular and bacterial water contamination. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=144 SRC="FIGDIR/small/530486v1_ufig1.gif" ALT="Figure 1"> View larger version (42K): org.highwire.dtl.DTLVardef@1abdb61org.highwire.dtl.DTLVardef@1cfc550org.highwire.dtl.DTLVardef@1a33647org.highwire.dtl.DTLVardef@40829e_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIIn a model freshwater system used both as drinking water and wastewater disposal, C_LIO_LIBacterial and genetic material differ between water and sediment compartments C_LIO_LILive bacteria C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

de Santana, C. O., Spealman, P., Gresham, D. J., Dueker, M. E., Perron, G. G.. 2023-02-28. Bacterial and molecular contamination of a small freshwater effluent used for drinking water. https://doi.org/10.1101/2023.02.28.530486

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗